Ronald Shebuski
Chief Tech/Sci/R&D Officer presso GENE BIOTHERAPEUTICS, INC.
Profilo
Ronald J.
Shebuski was the founder of Cardiovascular Research Consulting LLC (founded in 1998) and Aursos, Inc. (founded in 2007), where he held the title of Director & Chief Scientific Officer.
His current job(s) include being a Professor at the University of Minnesota and serving as the Chief Scientific Officer at Taxus Cardium Pharmaceuticals Group, Inc.Dr. Shebuski's former job(s) include being the Director-Cardiovascular Therapeutics at Pharmacia & Upjohn, Inc. from 1990 to 1998, Vice President-Pre Clinical Research at Afmedica, Inc., Chief Scientific Officer & Vice President-Research at MedElute, Inc. from 2009 to 2012, and Vice President-Research & Development at InspiRx, Inc. from 2016 to 2020.
In terms of education, Dr. Shebuski obtained his undergraduate degree from the University of Wisconsin in 1976 and his doctorate degree from the University of Minnesota Medical School in 1985.
Posizioni attive di Ronald Shebuski
| Società | Posizione | Inizio |
|---|---|---|
| GENE BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 22/05/2020 |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | Corporate Officer/Principal | - |
Precedenti posizioni note di Ronald Shebuski
| Società | Posizione | Fine |
|---|---|---|
InspiRx, Inc.
 InspiRx, Inc. Medical SpecialtiesHealth Technology InspiRx, Inc. is a respiratory research and development company that aims to improve the overall quality of respiratory drug delivery using expertise and state-of-the-art technologies to manufacture novel products. The private company is based in Somerset, NJ. The company's mission is to restore normal physiologic functionality by using the lungs as a portal to deliver medication for the treatment of respiratory and other disorders. | Chief Tech/Sci/R&D Officer | 01/01/2020 |
| Cardiovascular Research Consulting LLC | Founder | 01/01/2016 |
| Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | 01/01/1998 |
Afmedica, Inc.
 Afmedica, Inc. Pharmaceuticals: MajorHealth Technology Afmedica, Inc. develops medical and drug products. It develops perivascular technology using the drug rapamycin to treat peripheral vascular disease, coronary artery disease, and end stage renal disease. The company was founded in 2002 and is located in Kalamazoo, MI. | Corporate Officer/Principal | - |
Aursos, Inc.
 Aursos, Inc. Pharmaceuticals: MajorHealth Technology Aursos, Inc. develops and markets biopharmaceutical products. The company was founded by Seth Donahue and Ronald J. Shebuski Sr. in March 2007 and is headquartered in Kalamazoo, MI. | Founder | - |
Formazione di Ronald Shebuski
| University of Wisconsin | Undergraduate Degree |
| University of Minnesota Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GENE BIOTHERAPEUTICS, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
| Pharmacia & Upjohn, Inc. | Health Technology |
Afmedica, Inc.
Afmedica, Inc. Pharmaceuticals: MajorHealth Technology Afmedica, Inc. develops medical and drug products. It develops perivascular technology using the drug rapamycin to treat peripheral vascular disease, coronary artery disease, and end stage renal disease. The company was founded in 2002 and is located in Kalamazoo, MI. | Health Technology |
MedElute, Inc.
 MedElute, Inc. Electronic Equipment/InstrumentsElectronic Technology MedElute Inc. developed drug-eluting materials for treating post-surgical adhesions. Post-surgical adhesion formation is a natural consequence of surgery, resulting when tissue repairs itself following incision, cauterization, suturing, or other means of trauma. The company was founded in 2005 and is headquartered in Kalamazoo, MI. | Electronic Technology |
Aursos, Inc.
Aursos, Inc. Pharmaceuticals: MajorHealth Technology Aursos, Inc. develops and markets biopharmaceutical products. The company was founded by Seth Donahue and Ronald J. Shebuski Sr. in March 2007 and is headquartered in Kalamazoo, MI. | Health Technology |
InspiRx, Inc.
InspiRx, Inc. Medical SpecialtiesHealth Technology InspiRx, Inc. is a respiratory research and development company that aims to improve the overall quality of respiratory drug delivery using expertise and state-of-the-art technologies to manufacture novel products. The private company is based in Somerset, NJ. The company's mission is to restore normal physiologic functionality by using the lungs as a portal to deliver medication for the treatment of respiratory and other disorders. | Health Technology |
| Cardiovascular Research Consulting LLC |
- Borsa valori
- Insiders
- Ronald Shebuski
